彻底改变心脏护理:人工智能在心脏衰竭管理中的应用
Areeba Fareed1, Rayyan Vaid1, Abdulrahmon Moradeyo2
1From the Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan.
Cardiology in review
|January 9, 2025
概括
人工智能 (AI) 通过改善诊断,风险预测和治疗策略来增强心力衰竭 (HF) 护理. 人工智能工具分析复杂的数据,用于早期检测和个性化管理,从而改善患者的治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 计算机科学 计算机科学
- 心脏病学 心脏病学
背景情况:
- 心力衰竭 (HF) 构成了全球健康的重大负担,需要先进的诊断和管理工具.
- 传统的HF诊断和风险评估方法在精度和早期检测方面存在局限性.
- 人工智能 (AI) 为克服心血管医学中的这些挑战提供了潜在的解决方案.
研究的目的:
- 审查人工智能对心力衰竭的诊断,风险分层和治疗的影响.
- 突出AI在分析复杂的生理数据方面的能力,以改善高频检测和预测.
- 讨论人工智能在治疗高血压患者 (包括糖尿病患者) 和预测住院患者中的作用.
主要方法:
- 对心脏病学中人工智能应用的最新文献进行分析,重点关注心力衰竭.
- 评估人工智能模型在任务中的表现,例如使用心率变化来区分健康和危险个体.
- 对AI驱动的临床决策支持系统和高频预测算法的评估.
- 审查AI在识别心电图和其他生物标志物的微妙异常方面的实用性.
主要成果:
- 人工智能模型通过分析心率变化来识别患有充血性心力衰竭 (HF) 风险的个体,表现出卓越的表现.
- 基于人工智能的临床决策支持系统与高频专家诊断的高度一致.
- 人工智能算法有效地检测到心电图和其他预测器中的微妙不规则,以减少和保留射出分数.
- 人工智能准确地预测糖尿病患者的HF风险,并预测与HF相关的住院病例,从而实现主动干预.
结论:
- 人工智能正在彻底改变心力衰竭的护理,提供更高的诊断准确性,精确的风险评估和改进的治疗策略.
- 人工智能通过分析复杂的数据集和预测不良事件来促进HF的早期检测和个性化管理.
- 持续的研究和道德考虑对于人工智能在心力衰竭管理中的负责任和有效整合至关重要,以改善患者的治疗结果.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Heart Failure Drugs: Inotropic Agents
515
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
515
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers
314
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338


